2367 — Giant Biogene Holding Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesSpeculativeLarge CapHigh Flyer

Annual balance sheet for Giant Biogene Holding Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	819	1,956	7,259	2,197	3,779
Net Total Accounts Receivable
Net Total Receivables	22.3	56.3	76.3	93.7	127
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,458	2,284	7,441	2,538	4,135
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	300	281	334	552	712
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,797	2,651	7,878	3,138	4,973
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	626	2,174	6,843	281	531
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	649	2,193	6,861	305	611
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	1,148	458	1,017	2,833	4,362
Total Liabilities & Shareholders' Equity	1,797	2,651	7,878	3,138	4,973
Total Common Shares Outstanding